Displaying 1-11 of 11 result(s).
| Board Name | Posts By Silver | Post Created |
|---|---|---|
| SEEK Thedirectory.Com Inc | be ready for the big step upwards t | 11/20/2013 12:48:19 AM |
| SEEK Thedirectory.Com Inc | or you can find yourself chasing... | 11/13/2013 3:37:40 PM |
| SEEK Thedirectory.Com Inc | better thing to do is stop watching | 11/13/2013 1:41:17 PM |
| SEEK Thedirectory.Com Inc | That is just what MM wants you to d | 11/13/2013 1:39:13 PM |
| SEEK Thedirectory.Com Inc | I was stupid, not brave... I've cov | 11/09/2013 1:23:04 AM |
| SEEK Thedirectory.Com Inc | i like rough rides ;-) In the EYSM | 11/09/2013 1:04:30 AM |
| SEEK Thedirectory.Com Inc | Well I've been reading both front t | 11/09/2013 12:37:25 AM |
| SEEK Thedirectory.Com Inc | HOLD... this is the nervous part... | 11/08/2013 2:02:38 PM |
| SEEK Thedirectory.Com Inc | I've been into SEEK since the share | 10/24/2013 7:19:21 AM |
| SEEK Thedirectory.Com Inc | TheDirectory.com Signs Acquisition | 03/28/2013 12:11:27 PM |
| SEEK Thedirectory.Com Inc | Hello I have invested in EYSM - tha | 03/19/2013 11:20:26 AM |
Recent Articles
- POET Technologies Secures $150 Million in Investment for Growth
- Perseus Mining Reports Strong Operational Results for Q3 2025
- Secure Your Rights: Quantum Corporation Investors Must Act Now
- Investors Urged to Act Ahead of Semler Scientific Class Action
- Cygnus Metals Welcomes New CEO to Spearhead Future Growth
- Cygnus Announces Leadership Changes with New CEO Appointment
- Nyrstar NV Faces Appeal Following FSMA Sanctions Committee Ruling
- MapLight Therapeutics: Pioneering Solutions for CNS Disorders
- MapLight Therapeutics Sets Price for Its Highly Anticipated IPO
- Stay Informed: Key Legal Updates for Dow Inc. Investors
- Medtronic's Innovative Blood Pressure Treatments Show Long-Term Success
- Tronox Holdings PLC Investors Urged to Act Before Deadline
- CAPHRA's Asia Day: A Vital Approach to Tobacco Harm Reduction
- Influential Tech Leaders Shape Policy Decisions on Troops
- Transformative Financial Insights from Warren Buffett for the Elite
- Corporate Giants Fuel Trump's $300 Million Ballroom Dream
- Apple Inc. Enhances iPad Pro with Vapor Chamber Technology
- LifeMD, Inc.: Investors Encouraged to Claim Their Rights
- Breaking News: Louvre Heist Culprits Arrested in France
- Anthony Scaramucci Voices Support for Changpeng Zhao's Pardon
- General Motors Ditches CarPlay: A Shift Towards Innovation
- Exploring Trump's Bold Strategy of Gold for Bitcoin Exchange
- Cristcot Showcases Promising UC Treatment Data at Annual Meeting
- Innovative TissueCypher Test Enhances Management of Barrett's Esophagus
- Seniors Express Concerns as Social Security Payments Increase
- Castle Biosciences Unveils Key Data on TissueCypher at ACG
- Cordis Announces Innovative Results from Groundbreaking Trials
- Shaquille O'Neal's Luxury SUV Stolen in Cyber Heist
- Marex Group plc Securities Class Action Update and Guidance
- How the Fed's Balance Shift Could Impact Bitcoin Prices
- ARETI International Group Sponsors Mayflower Gran Prix 2025
- Big Week for Stocks: Major Gainers and Surprising Trends
- Microsoft's Strategic Shift in AI Development and Ethics
- U.S.-China Trade Agreement: Impact on Economy and Relations
- Recent Trends in Large Cap Stocks: Key Market Movers
- Avidity Biosciences Announces Acquisition by Novartis AG Deal
- Legal Action Encouraged for Designer Brands Inc. Investors
- Exploring the Future of Kratom: Insights from Kratom Bird
- Novartis Enhances Neuroscience Pipeline Through Avidity Biosciences Acquisition
- EggNest™ System: A Breakthrough in Radiation Safety for Cath Labs
- Critical Importance of Court Reporting in High-Profile Trials
- Mark Cuban's Insight: Billionaires and Market Stability
- Blockchain Jungle 2025: Experience Innovation in Technology
- Fortinet Shareholders Urged to Join Securities Class Action
- Controversial $130 Million Donation to Pentagon Raises Concerns
- Fate Therapeutics: Advances in CAR T-Cell Therapy for Lupus
- JPMorgan Faces Legal Challenge Over Excessive Fraud Fees
- JPMorgan Fights $115 Million Legal Fees After Fraud Case
- Fate Therapeutics Unveils Promising Data on FT819 CAR T-Cell Therapy
- Baxter International, Inc. Faces Class Action Lawsuit Amid Losses